Literature DB >> 9488271

Malignant tumors of the eyelid: a population-based study of non-basal cell and non-squamous cell malignant neoplasms.

C E Margo1, Z D Mulla.   

Abstract

OBJECTIVE: To determine the relative frequencies, average annual incidences, and patient characteristics of non-basal cell and non-squamous cell malignant neoplasms of the eyelid in a defined geographic population. DESIGN AND
SETTING: A retrospective study using the Florida Cancer Data System to identify malignant tumors of the eyelid, except for basal cell and squamous cell carcinomas, from 1981 through 1994. Cases were limited to persons who resided within Florida. MAIN OUTCOME MEASURE: Incidence of histologically confirmed malignant eyelid tumors.
RESULTS: Two hundred six primary malignant eyelid tumors were identified. The 3 most common, in order of frequency, were melanoma, sebaceous carcinoma, and lymphoma. The median age at diagnosis for all patients was 73 years. Only 3 of the 206 malignant neoplasms occurred in blacks. The annual incidence of eyelid melanoma and sebaceous carcinoma in whites older than 20 years was 0.6 and 0.5 per million, respectively. Kaposi sarcoma was the most common type of mesenchymal tumor. Eleven different histologic types of lymphoma were found in the eyelid. Only 2 of 27 lymphomas had T-cell lineage.
CONCLUSIONS: Malignant tumors of the eyelid other than basal cell and squamous cell carcinoma are uncommon and usually occur in elderly white persons. Primary eyelid tumors of any type are rare in blacks. The risk of a non-basal cell and non-squamous cell malignant neoplasm of the eyelid in Florida is 6.4 times greater for whites than for blacks (95% confidence interval [CI], 2.1-20.2). A variety of B-cell lymphomas can be manifested as primary eyelid tumors.

Entities:  

Mesh:

Year:  1998        PMID: 9488271     DOI: 10.1001/archopht.116.2.195

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  9 in total

1.  Sebaceous cell carcinoma of scalp - a rare presentation.

Authors:  Venkata Murali Krishna Bhavarajua; S Ejaz Shamim; V R Naik; Shamsol Shaari
Journal:  Malays J Med Sci       Date:  2007-01

Review 2.  Eyelid angiosarcoma: a case report and review of the literature.

Authors:  Hakan Demirci; Murray D Christanson
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Jul-Sep

3.  miR-196b-5p and miR-107 Expression Differentiates Ocular Sebaceous Carcinoma from Squamous Cell Carcinoma of the Conjunctiva.

Authors:  Ronald O B de Keizer; Anne L M Vriends; Gijsbert J Hötte; Dion A Paridaens; Erik A C Wiemer; Robert M Verdijk
Journal:  Int J Mol Sci       Date:  2022-04-28       Impact factor: 6.208

4.  Incidence of cutaneous sebaceous carcinoma and risk of associated neoplasms: insight into Muir-Torre syndrome.

Authors:  Graça M Dores; Rochelle E Curtis; Jorge R Toro; Susan S Devesa; Joseph F Fraumeni
Journal:  Cancer       Date:  2008-12-15       Impact factor: 6.860

5.  Epidemiology and Survival Outcomes for Eyelid Primary Malignant Melanoma: An Analysis of 1397 Cases in the SEER Database.

Authors:  Yi Shan; Yufeng Xu; Yuexin Lu; Menglu Chen; Jing Cao; Yijie Wang; Xiling Lin; Juan Ye
Journal:  J Ophthalmol       Date:  2020-12-08       Impact factor: 1.909

6.  Left Buttock Sebaceus Carcinoma: A Case Report and Review of the Literature.

Authors:  Răzvan Mercuţ; Mihaela Ionescu; Cristiana Simionescu; Vlad Pîrvănescu; Maria Filoftea Mercuţ; Alexandru Gogănău; Marius Eugen Ciurea
Journal:  Curr Health Sci J       Date:  2021-12-31

7.  Incidence of Cutaneous Melanoma of Eyelid Analysis of the Surveillance, Epidemiology, and End Results Database.

Authors:  Philip Brunetti; Curtis E Margo; Dustin D French
Journal:  Ocul Oncol Pathol       Date:  2020-11-17

8.  Lrig1 Expression in Human Sebaceous Gland Tumors.

Authors:  Jöri Pünchera; Laurent Barnes; Gürkan Kaya
Journal:  Dermatopathology (Basel)       Date:  2016-06-01

9.  Establishment and Characterization of a Novel Human Ocular Adnexal Sebaceous Carcinoma Cell Line.

Authors:  Andrew J Rong; Ryan A Gallo; Michelle G Zhang; Ravi Doddapaneni; Anthony J Griswold; John Y Lee; Stefan Kurtenbach; Sander R Dubovy; David T Tse; Daniel Pelaez
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.